0
Abstract: Poster Presentations |

STAGE-SPECIFIC PHARMACOGENOMICS IN A SURGICAL SHUNT MODEL OF PULMONARY ARTERIAL HYPERTENSION: ANALYSIS BY ENDOARTERIAL BIOPSY FREE TO VIEW

Abraham Rothman, MD; Stephanie Davidson, MD; Robert Wiencek, MD; Humberto Restrepo, MD; Val Sarukhanov, DVM; William E. Evans, MD; Roy Williams, PhD; Erkki Ruoslahti, MD; David Mann, BS*
Author and Funding Information

Vascular BioSciences, San Diego, CA


Chest


Chest. 2008;134(4_MeetingAbstracts):p135002. doi:10.1378/chest.134.4_MeetingAbstracts.p135002
Text Size: A A A
Published online

Abstract

PURPOSE: The aim of this study was to obtain endoarterial biopsy samples in a surgical porcine model of PAH in order to construct a microarray-based map of changes in gene expression in the arterial wall during PAH progression.

METHODS: Pigs underwent surgical anastomosis of the left pulmonary artery to the descending aorta, resulting in left PAH of at least ½ systemic level. Endovascular samples were obtained from 2–3 mm arteries with an endoarterial biopsy catheter at baseline (prior to surgery), and from the hypertensive left lung 21 and 60 days after surgery. RNA, isolated from biopsy samples, was loaded into an Affymetrix GeneChip Porcine Whole Genome Array. Gene expression level differences between samples from baseline, 21- and 60-day time-points were then analyzed. Gene expression changes relative to baseline were then used to identify the expression of dysregulated genes previously described to be associated with PAH as well as new upregulated genes, for which there are known inhibitors, in order to identify existing drugs which could potentially be used to treat or prevent PAH.

RESULTS: Data were obtained from 4 animals. The validity of the model was confirmed by examining the expression changes for selected genes previously found to be dysregulated in PAH, such as EDN1, TIE2, TGFB2, 5-HT2B, BIRC5, ANG2 which were upregulated, eNOS3, iNOS, APOE, PPARG which were downregulated. Genes with known inhibitors currently in use or under investigation for PAH, such as EDNRB, HTR2B, PDGFRA, HMGCR, KCNB1 were also found to be upregulated in our model. Interestingly, genes for which there are known inhibitors, but no previous association with PAH such as C5, HPSE, MAOB, HDAC2, CXCR4, IFNAR2, PREP, RRM1, POLG, RARB, HPRT1, CDK7, ADORA3, KCNJ2, CCR5, LTB4R2, MAOA, TLR8 were also found to be upregulated. Gene dysregulation varied between time points.

CONCLUSION: Endoarterial biopsy provides a new method to assess pulmonary vascular gene expression and identify novel PAH applications for existing drugs.

CLINICAL IMPLICATIONS: The detection of stage-specific variation in gene expression could lead to individualized pharmacogenomics.

DISCLOSURE: David Mann, Shareholder Shareholder, Vascular BioSciences; Employee Employee, Vascular BioSciences; Product/procedure/technique that is considered research and is NOT yet approved for any purpose. Endoarterial biopsy catheter

Wednesday, October 29, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
Guidelines
Management of endometriosis.
American College of Obstetricians and Gynecologists
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543